M, S., JL, P., & J, A. (2021). Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging. Dove Medical Press.
Chicago Style (17th ed.) CitationM, Salas, Potenziano JL, and Acker J. Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging. Dove Medical Press, 2021.
MLA (8th ed.) CitationM, Salas, et al. Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging. Dove Medical Press, 2021.
Warning: These citations may not always be 100% accurate.